Quantitative profiling of neurotransmitter abnormalities in brain, cerebrospinal fluid, and serum of experimental diabetic encephalopathy male rat.
Han, Xiaowen; Min, Mengjun; Wang, Juan; Bao, Zejun; Fan, Hongbin; Li, Xinyu; Adelusi, Temitope Isaac; Zhou, Xueyan; Yin, Xiaoxing.
J Neurosci Res
; 96(1): 138-150, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-28609588
Cellular response of the blood-brain barrier to injury: Potential biomarkers and therapeutic targets for brain regeneration.
Proteomics in the Diagnosis of Inborn Encephalopathies of Unknown Origin: A Myth or Reality.
Metabolomics: beyond biomarkers and towards mechanisms.
Melatonin improves the therapeutic role of mesenchymal stem cells in diabetic rats.
Epigenetic regulation of ageing: linking environmental inputs to genomic stability.
Developing retinal biomarkers of neurological disease: an analytical perspective.
Quantitative-profiling of neurotransmitter abnormalities in the disease progression of experimental diabetic encephalopathy rat.
Bone turnover markers in sheep and goat: A review of the scientific literature.
Assessment of Venous Thrombosis in Animal Models.
The S100B protein in biological fluids: more than a lifelong biomarker of brain distress.